Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study
Authors:
- Tunahan KirabaliTKTunahan Kirabali
- Luka KulicLKLuka Kulic
- Roger M. NitschRNRoger M. Nitsch
- Maria Teresa FerrettiMFMaria Teresa Ferretti
- 7 February 2018
- journal article
- research article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 18 (1) , 49-56
Abstract
Background: Strong genetic and epidemiological evidence points to a crucial role of the immune system in the development of Alzheimer disease (AD). CD3+ T lymphocytes have been described in brains of postmortem AD patients and in transgenic models of AD-like cerebral amyloidosis and tau pathology. However, the occurrence of T cells in AD brains is still controversial; furthermore, the relationship between T cells and hallmarks of AD pathology (amyloid plaques and neurofibrillary tangles) remains to be established. Objectives: We have studied the occurrence of T cells in postmortem hippocampi and mid frontal gyrus (MFG) samples of AD patients (Braak stage V-VI) and nondemented control subjects and correlated it with amyloid and tau pathology burden. Methods: Confocal microscopy and bright-field immunohistochemistry were used to identify brain-associated T cells. Extravascular CD3+ T cells were quantified and compared to nondemented controls. In addition, numbers of extravascular CD3+ T cells were correlated with amyloid (6E10 staining) and tau pathology (AT8 staining) in the same sections. Results: Several CD3+, extravascular T cells were observed in the brains of AD patients, mostly of the CD8+ subtype. AD hippocampi harbored significantly increased numbers of extravascular CD3+ T cells compared to nondemented controls. CD3+ T cells significantly correlated with tau pathology but not with amyloid plaques in AD samples. Conclusions: Our data support the notion of T-cell occurrence in AD brains and suggest that, in advanced stages of AD, T-cell extravasation is driven by tau-related neurodegenerative changes rather than by cerebral amyloidosis. T cells could be crucial for driving the amyloid-independent phase of the AD pathology.Keywords
This publication has 28 references indexed in Scilit:
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Immune surveillance in the central nervous systemNature Neuroscience, 2012
- The blood–brain barrier, chemokines and multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- CD4-Positive T Lymphocytes Provide a Neuroimmunological Link in the Control of Adult Hippocampal NeurogenesisThe Journal of Immunology, 2009
- Inflammatory changes parallel the early stages of Alzheimer diseaseNeurobiology of Aging, 2007
- Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthoodNature Neuroscience, 2006
- Induction of Inflammatory Mediators and Microglial Activation in Mice Transgenic for Mutant Human P301S Tau ProteinThe American Journal of Pathology, 2004
- Inflammatory factors are elevated in brain microvessels in Alzheimer's diseaseNeurobiology of Aging, 2001
- Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissueNeuroscience Letters, 1988
- Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's diseaseNeurobiology of Aging, 1988